Vas Narasimhan

826 total citations
11 papers, 608 citations indexed

About

Vas Narasimhan is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Vas Narasimhan has authored 11 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in Vas Narasimhan's work include Influenza Virus Research Studies (3 papers), Pneumonia and Respiratory Infections (3 papers) and Streptococcal Infections and Treatments (3 papers). Vas Narasimhan is often cited by papers focused on Influenza Virus Research Studies (3 papers), Pneumonia and Respiratory Infections (3 papers) and Streptococcal Infections and Treatments (3 papers). Vas Narasimhan collaborates with scholars based in United States, Switzerland and South Africa. Vas Narasimhan's co-authors include Eduardo Forleo‐Neto, Giovanni Della Cioppa, Karen S. Slobod, Nancy Bermal, Uwe Nicolay, Sharon E. Frey, Humberto Reynales, Ashwani Kumar Arora, Anthonet Koen and Lisa Jose and has published in prestigious journals such as Clinical Infectious Diseases, Science Translational Medicine and The Lancet Infectious Diseases.

In The Last Decade

Vas Narasimhan

10 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vas Narasimhan United States 8 409 152 114 103 90 11 608
Jonas Sundman Finland 4 242 0.6× 10 0.1× 93 0.8× 83 0.8× 143 1.6× 5 469
Peter Noble United Kingdom 15 79 0.2× 64 0.4× 73 0.6× 95 0.9× 28 0.3× 31 697
Janne Tynell Finland 11 137 0.3× 18 0.1× 127 1.1× 160 1.6× 32 0.4× 14 371
Manale Ouakki Canada 11 114 0.3× 13 0.1× 23 0.2× 146 1.4× 50 0.6× 27 375
Beth R. Larrabee United States 18 254 0.6× 32 0.2× 156 1.4× 131 1.3× 16 0.2× 31 725
Kristina Træholt Franck Denmark 13 135 0.3× 12 0.1× 128 1.1× 252 2.4× 25 0.3× 28 548
Michele Pallaoro Italy 6 143 0.3× 15 0.1× 256 2.2× 79 0.8× 89 1.0× 8 478
Reto Stricker Switzerland 7 125 0.3× 85 0.6× 46 0.4× 61 0.6× 13 0.1× 8 434
Dominique Louvel France 12 389 1.0× 90 0.6× 14 0.1× 151 1.5× 18 0.2× 25 1.1k
Pantaleo Nacci United States 8 261 0.6× 7 0.0× 117 1.0× 108 1.0× 14 0.2× 9 351

Countries citing papers authored by Vas Narasimhan

Since Specialization
Citations

This map shows the geographic impact of Vas Narasimhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vas Narasimhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vas Narasimhan more than expected).

Fields of papers citing papers by Vas Narasimhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vas Narasimhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vas Narasimhan. The network helps show where Vas Narasimhan may publish in the future.

Co-authorship network of co-authors of Vas Narasimhan

This figure shows the co-authorship network connecting the top 25 collaborators of Vas Narasimhan. A scholar is included among the top collaborators of Vas Narasimhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vas Narasimhan. Vas Narasimhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Finelli, Luca A. & Vas Narasimhan. (2020). Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development. Clinical Pharmacology & Therapeutics. 108(4). 756–761. 21 indexed citations
3.
Madhi, Shabir A., Anthonet Koen, Clare Cutland, et al.. (2017). Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy. Clinical Infectious Diseases. 65(11). 1897–1904. 40 indexed citations
4.
Madhi, Shabir A., Clare Cutland, Lisa Jose, et al.. (2016). Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. The Lancet Infectious Diseases. 16(8). 923–934. 119 indexed citations
5.
Volkmuth, Wayne, José S. Duca, Michele Pallaoro, et al.. (2015). Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. WOS. 1 indexed citations
6.
Volkmuth, Wayne, José S. Duca, Michele Pallaoro, et al.. (2015). Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Science Translational Medicine. 7(294). 294ra105–294ra105. 162 indexed citations
7.
Frey, Sharon E., Humberto Reynales, Nancy Bermal, et al.. (2014). Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 32(39). 5027–5034. 110 indexed citations
8.
9.
Oster, Gerry, John Edelsberg, Vas Narasimhan, et al.. (2014). Prevention of group B streptococcal disease in the first 3 months of life: Would routine maternal immunization during pregnancy be cost-effective?. Vaccine. 32(37). 4778–4785. 23 indexed citations
10.
Bart, Stephan, Matthew Hohenboken, Giovanni Della Cioppa, et al.. (2014). A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults. Science Translational Medicine. 6(234). 234ra55–234ra55. 78 indexed citations
11.
Block, Stan L., Leszek Szenborn, Teresa Jackowska, et al.. (2014). 1083Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults. Open Forum Infectious Diseases. 1(suppl_1). S319–S319. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Sundman Breakdown of academic impact, for papers by Peter Noble Breakdown of academic impact, for papers by Janne Tynell Breakdown of academic impact, for papers by Manale Ouakki Breakdown of academic impact, for papers by Beth R. Larrabee Breakdown of academic impact, for papers by Kristina Træholt Franck Breakdown of academic impact, for papers by Michele Pallaoro Breakdown of academic impact, for papers by Reto Stricker Breakdown of academic impact, for papers by Dominique Louvel Breakdown of academic impact, for papers by Pantaleo Nacci
Rankless by CCL
2026